Quantcast

Latest multiple sclerosis Stories

2014-03-24 12:24:47

Surveyed U.S. Payers Also Seek Improvements from New Agents in Effect on Disability, According to Findings from Decision Resources Group BURLINGTON, Mass., March 24, 2014 /PRNewswire/ -- Decision Resources Group finds that new disease-modifying therapies (DMTs) with improved efficacy in slowing disability progression present the greatest opportunity for drug developers in the treatment of relapsing-remitting multiple sclerosis (RR-MS). This finding is based on the relatively high level of...

Multiple Sclerosis May Benefit From Statins
2014-03-19 10:09:06

Brett Smith for redOrbit.com - Your Universe Online At first, multiple sclerosis is recognized by sporadic neurological symptoms – a condition called relapsing-remitting MS. Within a decade or so, greater than 50 percent of patients acquire secondary progressive MS, a continuous deterioration of symptoms and boost in disability. Currently, there are no approved drugs for treating this later stage of the disease. However, a newly published study in the UK medical journal The Lancet has...

2014-03-18 12:31:24

Patients Rapidly Shifting to New Oral Therapies PHILADELPHIA, March 18, 2014 /PRNewswire/ -- Health Union, LLC announced today on its website http://multiplesclerosis.net the topline results from its "2014 MS in America" survey of over 5,000 multiple sclerosis (MS) patients. This survey is one of the largest of its kind ever conducted. Symptoms - Diagnosis - Treatment Gap Even though scientific evidence[i] shows that early treatment can reduce the risk of disease progression,...

2014-03-18 08:29:03

For MS Awareness Month, MSAA Launches Effort to Get More People with MS in the Pool CHERRY HILL, N.J., March 18, 2014 /PRNewswire/ -- In honor of Multiple Sclerosis (MS) Awareness Month, the Multiple Sclerosis Association of America (MSAA), through a collaborative partnership with Genzyme, a Sanofi company, is proud to announce the stories from three individuals in the MS community who describe how swimming has helped manage their MS symptoms and improve their overall well-being. Today, MSAA...

2014-03-17 23:04:21

Crowdfunding Site Targeted to Raise $300K for FDA-Approved Adult Stem Cell Trial New York, NY (PRWEB) March 17, 2014 The Tisch MS Research Center of New York (Tisch MSRCNY) today announced that they have launched a dedicated campaign on Indiegogo to raise funds for their FDA-Approved Phase I Clinical Stem Cell Trial. The non-profit research center aims to raise $300K to be directly applied to the first twenty patients selected to participate in the clinical trial. “We are excited to...

2014-03-17 20:22:32

TOORAK, Australia, March 17, 2014 /PRNewswire/ -- Antisense Therapeutics (ASX:ANP) is pleased to advise that it has commenced dosing in its Phase I Stem Cell Mobilisation (SCM) Human Proof of Concept trial of ATL1102, the Company's second generation antisense drug targeting the VLA-4 receptor. The trial will assess the safety, tolerability and effect of ATL1102 on the release of hematopoietic stem cells (CD34+) into the blood when dosed alone and in combination with an existing...

2014-03-10 08:28:58

ROCKVILLE, Md., March 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced today that the U.S. Patent & Trademark Office has issued U.S. Patent No. 8,658,627 entitled, Pregnancy Hormone Combination for Treatment of Autoimmune Diseases, to the Regents of the University of California (UCLA). The patent includes claims to...

2014-03-06 12:27:02

ORLANDO, Fla., March 6, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) announced today that it has formed a new subsidiary, Cytocom, Inc., for the purpose of developing Low Dose Naltrexone (LDN) and Met-enkephalin (MENK). TNI BioTech has spent the last year developing a manufacturing and distribution network for sale of LDN into emerging nations and has had discussions with the FDA and EMA to begin clinical trials in the United States. The Company has considered whether to...

2014-03-03 23:01:42

Share Why You Connect to the MS Movement during MS Awareness Week March 3-9 as every connection counts at MSconnection.org towards the National MS Society's Vision for a world free of MS. New York, New York (PRWEB) March 03, 2014 Share Why You Connect to the MS Movement During MS Awareness Week March 3-9 2014 Every Connection Counts at MSconnection.org towards the National MS Society’s Vision for a World Free of MS Creating a world free of multiple sclerosis requires a collaborative...

2014-03-03 12:26:12

CHERRY HILL, N.J., March 3, 2014 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) recognizes March as MS Awareness Month. MSAA urges everyone to help raise awareness of multiple sclerosis throughout your community and help improve the lives today for people with MS and their families. MSAA offers the following ways to learn about MS and support the MS community: -- Visit our website, mymsaa.org, which provides easy access to vital information, resources,...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related